Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Webinar: Successful US medtech strategies

This article was originally published in Clinica

Executive Summary

While there is much talk about the growth opportunities in the emerging markets, the US continues to be the biggest and most significant market for medical devices, worth around $120bn in 2009 with an annual growth rate of 6%. Clinica hosted a webinar on 30 March 2011 with US consultants Dr Robert Keefer of TCG Medtech and Glenn Neumann of New World Regulatory Solutions to provide companies with an insight on the key trends in the US market and the regulatory landscape and recent developments at the FDA. The panellists also gave practical advice on how to tackle the market if you're a first-timer, such as how to identify and approach key opinion leaders to help launch your products; issues you need to address if you already have a presence in the US but your business is not living up to expectations; and the financial impact as FDA regulatory processes become more stringent.

You may also be interested in...



Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.

Topics

UsernamePublicRestriction

Register

MT097136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel